AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,163 Cr | ₹1,809 Cr | ₹867 Cr | ₹903 Cr | ₹807 Cr |
What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1,163 Cr |
| Mar2024 | ₹1,809 Cr |
| Mar2023 | ₹867 Cr |
| Mar2022 | ₹903 Cr |
| Mar2021 | ₹807 Cr |
How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,163 Cr | -35.72 | |
| Mar2024 | ₹1,809 Cr | 108.67 | |
| Mar2023 | ₹867 Cr | -4.01 | |
| Mar2022 | ₹903 Cr | 11.87 | |
| Mar2021 | ₹807 Cr | - | |
Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹68,604.1 Cr | -2.6% | -2.8% | -6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,376.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,174.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.6% |
-2.8% |
-6.6% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses